White blood cell count and all-cause and cause-specific mortality in the Guangzhou biobank cohort study
Open Access
- 6 November 2018
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1-9
Abstract
Several studies have shown positive associations between higher WBC count and deaths from all-causes, CHD, stroke and cancer among occidental populations or developed countries of Asia. No study on the association of WBC count with all-cause and cause-specific mortality in Chinese populations was reported. We studied this using prospective data from a large Chinese cohort. We used prospective data from the Guangzhou Biobank Cohort Study (GBCS), a total of 29,925 participants in present study. A Cox proportional hazards regression model was used to estimate the hazard ratios (HR) and 95% confidence interval (CI). The hazard ratios (HR) for all-cause, CHD, and respiratory disease mortality for the highest decile of WBC count (women > 8.2 × 109/L; men > 8.8 × 109/L) was 1.83 (95% confidence interval (CI) 1.54, 2.17), 3.02 (95% CI 1.84, 4.98) and 2.52 (95% CI 1.49, 4.27), respectively, after adjusting for multiple potential confounders. The associations were similar when deaths during the first 2 years of follow-up were excluded. After further adjusting for pulmonary function, the highest decile of WBC count was associated with 90% higher risk of respiratory disease mortality (HR 1.90, 95% CI 1.08, 3.33). No evidence for an association between higher WBC count and cancer mortality was found. Sub-type analysis showed that only granulocyte count remained significantly predictive of all-cause, CHD, and respiratory disease mortality. Elevated WBC, specifically granulocyte, count was associated with all-cause, CHD and respiratory mortality in southern Chinese. Further investigation is warranted to clarify whether decreasing inflammation would attenuate WBC count associated mortality.Keywords
Funding Information
- The University of Hong Kong Foundation for Educational Development and Research (SN/1f/HKUF-DC; C20400.28505200)
- the Health Medical Research Fund in HongKong (HMRF/13143241)
- The Guangzhou Public Health Bureau (201102A211004011)
- The Guangzhou Science and Technology Bureau (2002Z2-E2051; 2012J5100041; 2013J4100031)
- Natural Science Foundation of Guangdong and the University of Birmingham (2015A030313891)
This publication has 45 references indexed in Scilit:
- The Association between Systemic Inflammatory Cellular Levels and Lung Function: A Population-Based StudyPLOS ONE, 2011
- Vascular Endothelial Function Is Related to White Blood Cell Count and Myeloperoxidase Among Healthy Middle-Aged and Older AdultsHypertension, 2010
- Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort StudyAtherosclerosis, 2009
- Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC‐Norfolk Prospective Population StudyJournal of Internal Medicine, 2007
- Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort StudyThe Lancet, 2007
- White Blood Cell Count and Mortality in the Baltimore Longitudinal Study of AgingJACC, 2007
- Cohort Profile: The Guangzhou Biobank Cohort Study, a Guangzhou–Hong Kong–Birmingham collaborationInternational Journal of Epidemiology, 2006
- White blood cell count and hypertensionJournal of Human Hypertension, 2006
- White Blood Cell Count and Risk for All-Cause, Cardiovascular, and Cancer Mortality in a Cohort of KoreansAmerican Journal of Epidemiology, 2005
- Leukocytes as a coronary risk factor in a dyslipidemic male populationAmerican Heart Journal, 1992